(Q33745865)

29 July 2017

title

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants (English)

1 reference

29 July 2017

1 reference

J D Goldberg

1

1 reference

29 July 2017

J Zheng

2

1 reference

29 July 2017

H Castro-Malaspina

3

1 reference

29 July 2017

A A Jakubowski

4

1 reference

29 July 2017

G Heller

5

1 reference

29 July 2017

M R M van den Brink

6

1 reference

29 July 2017

M-A Perales

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

2 July 2012

1 reference

Bone Marrow Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

48

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

99-104

1 reference

Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Purification and characterization of a newly identified growth factor specific for epithelial cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Large induction of keratinocyte growth factor expression in the dermis during wound healing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Increased radiation tolerance of mouse tongue epithelium after local conditioning.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054935

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2012.115

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2012.115

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2012.115

Modification of oral mucositis by keratinocyte growth factor: single radiation exposure

21 January 2018

1 reference

12 December 2020

Hyperfractionated total body irradiation for bone marrow transplantation. results in seventy leukemia patients with allogeneic transplants

1 reference

12 December 2020

Chronic graft-versus-host disease

1 reference

12 December 2020

A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease

1 reference

12 December 2020

Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice

1 reference

12 December 2020

Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice

1 reference

12 December 2020

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1 reference

12 December 2020

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

1 reference

12 December 2020

Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study

1 reference

12 December 2020

Ex vivo T cell depletion of allogeneic PBSC as acute and chronic GVHD prophylaxis after myeloablative HCT: time to reconsider?

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2012.115

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference